ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 439

$491K Total Retail Price of All Prescriptions

Rank: 75 out of 439

346 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 346 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 5,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 386 239 1 3
HYDROCODONE-ACETAMINOPHEN 349 162 S3 2 1
AMLODIPINE BESYLATE 271 167 3 2
RANITIDINE HCL 269 144 4 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 259 205 5 63
OMEPRAZOLE 198 102 6 6
CARVEDILOL 193 132 7 8
LISINOPRIL 192 124 8 4
HYDROCHLOROTHIAZIDE 181 126 9 18
FUROSEMIDE 180 122 10 5
LEVOTHYROXINE SODIUM 169 112 11 9
METFORMIN HCL 165 95 12 29
TRAMADOL HCL 148 78 13 21
ACTOS 147 88 14 225
MELOXICAM 134 100 15 40
ALLOPURINOL 111 94 16 54
LOSARTAN-HYDROCHLOROTHIAZIDE 104 92 17 91
AMLODIPINE BESYLATE-BENAZEPRIL 103 62 18 162
KLOR-CON M20 94 67 19 77
METOPROLOL TARTRATE 94 58 19 11
GABAPENTIN 93 44 21 7
ISOSORBIDE MONONITRATE ER 93 71 21 28
ADVAIR DISKUS 89 34 23 36
METOLAZONE 88 56 24 208
CLOPIDOGREL 83 71 25 16
GLYBURIDE-METFORMIN HCL 80 36 R 26 306
POTASSIUM CHLORIDE 80 38 26 30
INDAPAMIDE 78 44 28 369
LOVASTATIN 77 66 29 103
NEXIUM 75 60 30 32
MISOPROSTOL 74 38 31 373
LOSARTAN POTASSIUM 73 44 32 31
ETODOLAC 73 31 32 376
HYDRALAZINE HCL 72 59 34 55
NAPROXEN 69 43 35 181
IBUPROFEN 68 13 36 218
PROAIR HFA 67 28 37 53
INSULIN SYRINGE 66 18 38 78
ZOLPIDEM TARTRATE 66 25 38 14
CLONIDINE HCL 66 25 38 47
CYCLOBENZAPRINE HCL 66 43 R 38 49
LEVETIRACETAM 64 22 42 42
TRIAMTERENE-HCTZ 63 41 43 112
DONEPEZIL HCL 63 63 43 22
PIOGLITAZONE HCL 62 33 R 45 335
RAMIPRIL 62 13 45 118
GLIMEPIRIDE 57 31 47 61
GLIPIZIDE 56 44 48 120
TRIAMCINOLONE ACETONIDE 55 32 49 87
WARFARIN SODIUM 55 36 49 10
PHENYTOIN SODIUM EXTENDED 54 26 51 190
COLCRYS 54 41 51 201
FELODIPINE ER 54 54 51 321
DIOVAN HCT 53 41 54 128
PROMETHAZINE HCL 52 14 R 55 68
METOPROLOL SUCCINATE 52 26 55 13
COMBIVENT 50 17 57 153
FLUOXETINE HCL 50 18 57 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.